IP Library Granted Patent US 10,662,453
Granted Patent B2
US 10,662,453 · App. 16/122,050 · Granted May 26, 2020

Compositions and methods for making (S)-norcoclaurine and (S)-norlaudanosoline, and synthesis intermediates thereof

Inventor: Peter James Facchini (Calgary, CA)
Assignee: Willow BioSciences Inc.
C12P17/12C12N9/0022C12N9/0059C12N9/88C12P7/24C12P13/001C12P13/22C12N15/8243C12P17/182C12Y201/01128
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,662,453
App. No.
16/122,050
Granted
May 26, 2020
Kind
B2
Abstract

Methods that may be used for the manufacture of the chemical compound (S)-norcoclaurine, (S)-norlaudanosoline, and (S)-norcoclaurine or (S)-norlaudanosoline synthesis intermediates are provided. (S)-Norcoclaurine, (S)-norlaudanosoline, and (S)-norcoclaurine or (S)-norlaudanosoline synthesis intermediates are useful as precursor products in the manufacture of certain medicinal agents.

Claims (12)

1. A host cell comprising a heterologous chimeric nucleic acid sequence comprising a promoter capable of controlling expression in the host cell linked to a nucleic acid sequence encoding norcoclaurine synthase (NCS), wherein norcoclaurine synthase (NCS) is a polypeptide having a sequence selected from the group of sequences set forth in SEQ ID NO:13; SEQ ID NO:14; SEQ ID NO:17; SEQ ID NO:28; SEQ ID NO:34; and SEQ ID NO:42; or is encoded by SEQ ID NO:109; or SEQ ID NO:113.

2. The host cell according to claim 1 , wherein the host cell is able to produce at least one of L-tyrosine, L-DOPA, dopamine, tyramine, 4-hydroxy-phenylacetaldehyde (4-HPAA), and 3,4-dihydroxy-phenylacetaldehyde (3,4-DHPAA), and wherein the host cell is unable to produce (S)-norcoclaurine or (S)-norlaudanosoline, in the absence of the chimeric nucleic acid sequence.

3. The host cell according to claim 1 wherein the nucleic acid sequence encoding NCS further comprises a nucleic acid sequence selected from the group consisting of a nucleic acid sequence encoding tyrosine hydroxylase (TYR), a nucleic acid sequence encoding tyrosine decarboxylase (TYDC) and a nucleic acid sequence encoding dihydroxyphenylalanine decarboxylase (DODC).

4. The host cell according to claim 1 , wherein the host cell is a microbial cell or a plant cell.

5. The host cell according to claim 4 , wherein the microbial cell is a bacterial cell or a yeast cell.

6. A recombinant expression vector comprising in the 5′ to 3′ direction of transcription as operably linked components:

(i) a nucleic acid sequence capable of controlling expression in a host cell; and

(ii) a nucleic acid sequence encoding norcoclaurine synthase (NCS), wherein the norcoclaurine synthase (NCS) is a polypeptide having a sequence selected from the group of sequences set forth in SEQ ID NO:13; SEQ ID NO:14; SEQ ID NO:17; SEQ ID NO:28; SEQ ID NO:34; and SEQ ID NO:42; or is encoded by SEQ ID NO:109; or SEQ ID NO:113.

7. The recombinant expression vector according to claim 6 wherein the vector further comprises a nucleic acid sequence selected from the group consisting of a nucleic acid sequence encoding tyrosine hydroxylase (TYR), a nucleic acid sequence encoding tyrosine decarboxylase (TYDC) and a nucleic acid sequence encoding dihydroxyphenylalanine decarboxylase (DODC).

8. The host cell according to claim 2 wherein the nucleic acid sequence encoding NCS further comprises a nucleic acid sequence selected from the group consisting of a nucleic acid sequence encoding tyrosine hydroxylase (TYR), a nucleic acid sequence encoding tyrosine decarboxylase (TYDC) and a nucleic acid sequence encoding dihydroxyphenylalanine decarboxylase (DODC).

9. The host cell according to claim 2 , wherein the host cell is a microbial cell or a plant cell.

10. The host cell according to claim 3 , wherein the host cell is a microbial cell or a plant cell.

Assignments (6)
SECURITY INTEREST Recorded Aug 29, 2025
From: ANTHEIA, INC.
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 072750/0812 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 9, 2025
From: WILLOW BIOSCIENCES, INC.
To: ANTHEIA, INC.
Reel/Frame 070785/0746 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2021
From: ELESZTO GENETIKA, INC.
To: ANTHEIA, INC.
Reel/Frame 055485/0062 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2020
From: WILLOW BIOSCIENCES, INC.
To: ELESZTO GENETIKA INC.
Reel/Frame 054082/0880 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2019
From: EPIMERON INC.
To: WILLOW BIOSCIENCES INC.
Reel/Frame 050970/0225 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2018
From: FACCHINI, PETER JAMES
To: EPIMERON INC.
Reel/Frame 046790/0752 →
Continuity (3)
Continuation 15319568
Provisional Application 62014367 · Jun 19, 2014
Related Publication 20190062793A1 · Feb 28, 2019